Skip to main content

Site notifications

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

1074 result(s) found, displaying 226 to 250
  • New AusPAR for ACTEMRA Tocilizumab (rch) for the treatment of coronavirus disease 2019 (COVID-19).
  • Australian Public Assessment Report for Elasomeran (mRNA-1273)
  • Australian Public Assessment Report for Pegvaliase
  • Australian Public Assessment Report for Regdanvimab
  • Australian Public Assessment Report for Adalimumab
  • Australian Public Assessment Report for Casirivimab/imdevimab
  • Australian Public Assessment Report for BNT162b2 (mRNA)
  • Australian Public Assessment Report for ChAdOx1-S - COVID-19 Vaccine AstraZeneca
  • Australian Public Assessment Report for Pertuzumab/trastuzumab
  • Australian Public Assessment Report for Eslicarbazepine acetate
  • Australian Public Assessment Report for Fostemsavir trometamol
  • Australian Public Assessment Report for Sofosbuvir/velpatasvir
  • Australian Public Assessment Report for Risdiplam
  • Australian Public Assessment Report for Elasomeran
  • Australian Public Assessment Report for Upadacitinib
  • Australian Public Assessment Report for Crizanlizumab
  • Australian Public Assessment Report for Satralizumab
  • Australian Public Assessment Report for Sotrovimab
  • Australian Public Assessment Report for Ofatumumab

Help us improve this page